Polymersomes with splenic avidity target red pulp myeloid cells for cancer immunotherapy.
Nature nanotechnology
View this publicationNature nanotechnology
View this publicationSeminars in immunopathology
View this publicationResearch square
View this publicationVaccine
View this publicationFrontiers in immunology
View this publicationVaccines
View this publicationCell surface (Amsterdam, Netherlands)
View this publicationCell
View this publicationiScience
View this publicationFrontiers in immunology
View this publication